Supplemental material
Journal of Asthma
Volume 59, 2022 - Issue 11
Open access
4,219
Views
18
CrossRef citations to date
0
Altmetric
Pharmacotherapy
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel,a Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USAView further author information
, MD, Giorgio Walter Canonica,b Personalized Medicine Asthma and Allergy Clinic, Department of Biomedical Sciences, Humanitas University and Research Hospital-IRCCS, Rozzano, Milan, ItalyView further author information
, MD, Guy Brusselle,c Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumView further author information
, MD, PhD, Shibing Yang,d Value Evidence and Outcomes, GSK, Collegeville, PA, USAView further author information
, PhD, Peter H. Howarth,e Global Specialty & Primary Care, GSK, Brentford, UKView further author information
, MD, PhD, Amber L. Martin,f Evidence Synthesis, Modeling & Communication, Evidera, Waltham, MA, USAView further author information
, PhD, Maria Koufopoulou,g Evidence Synthesis, Modelling & Communication, Evidera, London, UKView further author information
, PhD, Steven G. Smith,h Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USAView further author information
, PhD & Rafael Alfonso-Cristancho,d Value Evidence and Outcomes, GSK, Collegeville, PA, USACorrespondence[email protected]
View further author information
, MD, PhD show allView further author information
Pages 2201-2217
|
Received 07 Jul 2021, Accepted 16 Nov 2021, Published online: 24 Dec 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.